Emergent Biomarkers of Residual Cardiovascular Risk in Patients with Low HDL-c and/or High Triglycerides and Average LDL-c Concentrations: Focus on HDL Subpopulations, Oxidized LDL, Adiponectin, and Uric Acid

This study intended to determine the impact of HDL-c and/or TGs levels on patients with average LDL-c concentration, focusing on lipidic, oxidative, inflammatory, and angiogenic profiles. Patients with cardiovascular risk factors (n=169) were divided into 4 subgroups, combining normal and low HDL-c...

Full description

Saved in:
Bibliographic Details
Main Authors: Filipa Mascarenhas-Melo, Filipe Palavra, Daniela Marado, José Sereno, Edite Teixeira-Lemos, Isabel Freitas, Maria Isabel-Mendonça, Rui Pinto, Frederico Teixeira, Flávio Reis
Format: Article
Language:English
Published: Wiley 2013-01-01
Series:The Scientific World Journal
Online Access:http://dx.doi.org/10.1155/2013/387849
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832557108391837696
author Filipa Mascarenhas-Melo
Filipe Palavra
Daniela Marado
José Sereno
Edite Teixeira-Lemos
Isabel Freitas
Maria Isabel-Mendonça
Rui Pinto
Frederico Teixeira
Flávio Reis
author_facet Filipa Mascarenhas-Melo
Filipe Palavra
Daniela Marado
José Sereno
Edite Teixeira-Lemos
Isabel Freitas
Maria Isabel-Mendonça
Rui Pinto
Frederico Teixeira
Flávio Reis
author_sort Filipa Mascarenhas-Melo
collection DOAJ
description This study intended to determine the impact of HDL-c and/or TGs levels on patients with average LDL-c concentration, focusing on lipidic, oxidative, inflammatory, and angiogenic profiles. Patients with cardiovascular risk factors (n=169) were divided into 4 subgroups, combining normal and low HDL-c with normal and high TGs patients. The following data was analyzed: BP, BMI, waist circumference and serum glucose, Total-c, TGs, LDL-c, oxidized-LDL, total HDL-c and HDL subpopulations, paraoxonase-1 (PON1) activity, hsCRP, uric acid, TNF-α, adiponectin, VEGF, and iCAM1. The two populations with increased TGs levels, regardless of the normal or low HDL-c, presented obesity and higher waist circumference, Total-c, LDL-c, Ox-LDL, and uric acid. Adiponectin concentration was significantly lower and VEGF was higher in the population with cumulative low values of HDL-c and high values of TGs, while HDL quality was reduced in the populations with impaired values of HDL-c and/or TGs, viewed by reduced large and increased small HDL subfractions. In conclusion, in a population with cardiovascular risk factors, low HDL-c and/or high TGs concentrations seem to be associated with a poor cardiometabolic profile, despite average LDL-c levels. This condition, often called residual risk, is better evidenced by using both traditional and nontraditional CV biomarkers, including large and small HDL subfractions, Ox-LDL, adiponectin, VEGF, and uric acid.
format Article
id doaj-art-7a055e5f17ab42aab1477c07f73f988d
institution Kabale University
issn 1537-744X
language English
publishDate 2013-01-01
publisher Wiley
record_format Article
series The Scientific World Journal
spelling doaj-art-7a055e5f17ab42aab1477c07f73f988d2025-02-03T05:43:36ZengWileyThe Scientific World Journal1537-744X2013-01-01201310.1155/2013/387849387849Emergent Biomarkers of Residual Cardiovascular Risk in Patients with Low HDL-c and/or High Triglycerides and Average LDL-c Concentrations: Focus on HDL Subpopulations, Oxidized LDL, Adiponectin, and Uric AcidFilipa Mascarenhas-Melo0Filipe Palavra1Daniela Marado2José Sereno3Edite Teixeira-Lemos4Isabel Freitas5Maria Isabel-Mendonça6Rui Pinto7Frederico Teixeira8Flávio Reis9Laboratory of Pharmacology & Experimental Therapeutics, IBILI, Faculty of Medicine, Sub-Unit 1 (Pólo III), University of Coimbra, 3000-548 Coimbra, PortugalNeurology Department, General Hospital, University and Hospital Centre of Coimbra, Quinta dos Vales, São Martinho do Bispo, 3041-801 Coimbra, PortugalInternal Medicine Department, General Hospital, University and Hospital Centre of Coimbra, Quinta dos Vales, São Martinho do Bispo, 3041-801 Coimbra, PortugalLaboratory of Pharmacology & Experimental Therapeutics, IBILI, Faculty of Medicine, Sub-Unit 1 (Pólo III), University of Coimbra, 3000-548 Coimbra, PortugalLaboratory of Pharmacology & Experimental Therapeutics, IBILI, Faculty of Medicine, Sub-Unit 1 (Pólo III), University of Coimbra, 3000-548 Coimbra, PortugalResearch Unit, Central Hospital of Funchal, 9004-514 Funchal, Madeira, PortugalResearch Unit, Central Hospital of Funchal, 9004-514 Funchal, Madeira, PortugalPharmacology and Pharmacotoxicology Unit, Faculty of Pharmacy, University of Lisbon, 1649-003 Lisbon, PortugalLaboratory of Pharmacology & Experimental Therapeutics, IBILI, Faculty of Medicine, Sub-Unit 1 (Pólo III), University of Coimbra, 3000-548 Coimbra, PortugalLaboratory of Pharmacology & Experimental Therapeutics, IBILI, Faculty of Medicine, Sub-Unit 1 (Pólo III), University of Coimbra, 3000-548 Coimbra, PortugalThis study intended to determine the impact of HDL-c and/or TGs levels on patients with average LDL-c concentration, focusing on lipidic, oxidative, inflammatory, and angiogenic profiles. Patients with cardiovascular risk factors (n=169) were divided into 4 subgroups, combining normal and low HDL-c with normal and high TGs patients. The following data was analyzed: BP, BMI, waist circumference and serum glucose, Total-c, TGs, LDL-c, oxidized-LDL, total HDL-c and HDL subpopulations, paraoxonase-1 (PON1) activity, hsCRP, uric acid, TNF-α, adiponectin, VEGF, and iCAM1. The two populations with increased TGs levels, regardless of the normal or low HDL-c, presented obesity and higher waist circumference, Total-c, LDL-c, Ox-LDL, and uric acid. Adiponectin concentration was significantly lower and VEGF was higher in the population with cumulative low values of HDL-c and high values of TGs, while HDL quality was reduced in the populations with impaired values of HDL-c and/or TGs, viewed by reduced large and increased small HDL subfractions. In conclusion, in a population with cardiovascular risk factors, low HDL-c and/or high TGs concentrations seem to be associated with a poor cardiometabolic profile, despite average LDL-c levels. This condition, often called residual risk, is better evidenced by using both traditional and nontraditional CV biomarkers, including large and small HDL subfractions, Ox-LDL, adiponectin, VEGF, and uric acid.http://dx.doi.org/10.1155/2013/387849
spellingShingle Filipa Mascarenhas-Melo
Filipe Palavra
Daniela Marado
José Sereno
Edite Teixeira-Lemos
Isabel Freitas
Maria Isabel-Mendonça
Rui Pinto
Frederico Teixeira
Flávio Reis
Emergent Biomarkers of Residual Cardiovascular Risk in Patients with Low HDL-c and/or High Triglycerides and Average LDL-c Concentrations: Focus on HDL Subpopulations, Oxidized LDL, Adiponectin, and Uric Acid
The Scientific World Journal
title Emergent Biomarkers of Residual Cardiovascular Risk in Patients with Low HDL-c and/or High Triglycerides and Average LDL-c Concentrations: Focus on HDL Subpopulations, Oxidized LDL, Adiponectin, and Uric Acid
title_full Emergent Biomarkers of Residual Cardiovascular Risk in Patients with Low HDL-c and/or High Triglycerides and Average LDL-c Concentrations: Focus on HDL Subpopulations, Oxidized LDL, Adiponectin, and Uric Acid
title_fullStr Emergent Biomarkers of Residual Cardiovascular Risk in Patients with Low HDL-c and/or High Triglycerides and Average LDL-c Concentrations: Focus on HDL Subpopulations, Oxidized LDL, Adiponectin, and Uric Acid
title_full_unstemmed Emergent Biomarkers of Residual Cardiovascular Risk in Patients with Low HDL-c and/or High Triglycerides and Average LDL-c Concentrations: Focus on HDL Subpopulations, Oxidized LDL, Adiponectin, and Uric Acid
title_short Emergent Biomarkers of Residual Cardiovascular Risk in Patients with Low HDL-c and/or High Triglycerides and Average LDL-c Concentrations: Focus on HDL Subpopulations, Oxidized LDL, Adiponectin, and Uric Acid
title_sort emergent biomarkers of residual cardiovascular risk in patients with low hdl c and or high triglycerides and average ldl c concentrations focus on hdl subpopulations oxidized ldl adiponectin and uric acid
url http://dx.doi.org/10.1155/2013/387849
work_keys_str_mv AT filipamascarenhasmelo emergentbiomarkersofresidualcardiovascularriskinpatientswithlowhdlcandorhightriglyceridesandaverageldlcconcentrationsfocusonhdlsubpopulationsoxidizedldladiponectinanduricacid
AT filipepalavra emergentbiomarkersofresidualcardiovascularriskinpatientswithlowhdlcandorhightriglyceridesandaverageldlcconcentrationsfocusonhdlsubpopulationsoxidizedldladiponectinanduricacid
AT danielamarado emergentbiomarkersofresidualcardiovascularriskinpatientswithlowhdlcandorhightriglyceridesandaverageldlcconcentrationsfocusonhdlsubpopulationsoxidizedldladiponectinanduricacid
AT josesereno emergentbiomarkersofresidualcardiovascularriskinpatientswithlowhdlcandorhightriglyceridesandaverageldlcconcentrationsfocusonhdlsubpopulationsoxidizedldladiponectinanduricacid
AT editeteixeiralemos emergentbiomarkersofresidualcardiovascularriskinpatientswithlowhdlcandorhightriglyceridesandaverageldlcconcentrationsfocusonhdlsubpopulationsoxidizedldladiponectinanduricacid
AT isabelfreitas emergentbiomarkersofresidualcardiovascularriskinpatientswithlowhdlcandorhightriglyceridesandaverageldlcconcentrationsfocusonhdlsubpopulationsoxidizedldladiponectinanduricacid
AT mariaisabelmendonca emergentbiomarkersofresidualcardiovascularriskinpatientswithlowhdlcandorhightriglyceridesandaverageldlcconcentrationsfocusonhdlsubpopulationsoxidizedldladiponectinanduricacid
AT ruipinto emergentbiomarkersofresidualcardiovascularriskinpatientswithlowhdlcandorhightriglyceridesandaverageldlcconcentrationsfocusonhdlsubpopulationsoxidizedldladiponectinanduricacid
AT fredericoteixeira emergentbiomarkersofresidualcardiovascularriskinpatientswithlowhdlcandorhightriglyceridesandaverageldlcconcentrationsfocusonhdlsubpopulationsoxidizedldladiponectinanduricacid
AT flavioreis emergentbiomarkersofresidualcardiovascularriskinpatientswithlowhdlcandorhightriglyceridesandaverageldlcconcentrationsfocusonhdlsubpopulationsoxidizedldladiponectinanduricacid